Bcr-Abl
Bcr-Abl-Inhibitoren sind zielgerichtete Therapien, die das Bcr-Abl-Fusionsprotein hemmen, das durch die Philadelphia-Chromosomen-Translokation gebildet wird und ein Treiber der chronischen myeloischen Leukämie (CML) ist. Dieses Protein beeinflusst auch die Angiogenese und trägt zur Tumorprogression bei. Bcr-Abl-Inhibitoren sind entscheidend für die Behandlung von CML und werden auf ihr Potenzial zur Hemmung der Angiogenese bei verschiedenen Krebsarten untersucht. Bei CymitQuimica bieten wir hochwertige Bcr-Abl-Inhibitoren zur Unterstützung Ihrer Forschung in den Bereichen Krebsbiologie, Angiogenese und zielgerichtete Therapie an.
117 Produkte aus dem Bereich "Bcr-Abl" gefunden
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
Bosutinib
CAS:Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases.Formel:C26H29Cl2N5O3Reinheit:98.98% - 99.9%Farbe und Form:Yellowish-Orange Or Pink To Brownish Solid Solid PowderMolekulargewicht:530.45Dasatinib monohydrate
CAS:Dasatinib monohydrate, an oral SRC-kinase inhibitor, counters imatinib-resistant chronic myeloid leukemia.Formel:C22H28ClN7O3SReinheit:99.68% - >99.99%Farbe und Form:SolidMolekulargewicht:506.03Nilotinib
CAS:Nilotinib (AMN107) is a Bcr-Abl tyrosine kinase inhibitor. Nilotinib has antitumor activity and may be used in CML. Cost-effective and quality-assured.Formel:C28H22F3N7OReinheit:99.89% - >99.99%Farbe und Form:Off-White SolidMolekulargewicht:529.52Imatinib Mesylate
CAS:Imatinib Mesylate (STI-571) is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR,
Formel:C29H31N7O·CH4SO3Reinheit:98% - >99.99%Farbe und Form:White Crystalline PowderMolekulargewicht:589.71LXH254
CAS:LXH254 is a B/C RAF inhibitor with IC50 values of 0.2 nM and 0.07 nM for inhibiting BRAF and CRAF.Cost-effective and quality-assured.Formel:C25H25F3N4O4Reinheit:98.3% - 99.92%Farbe und Form:SolidMolekulargewicht:502.49Ref: TM-T11898
1mg52,00€5mg122,00€10mg185,00€25mg363,00€50mg567,00€100mg690,00€200mg948,00€500mg1.444,00€1mL*10mM (DMSO)135,00€N-Desmethyl imatinib
CAS:N-Desmethyl imatinib (Imatinib metabolite N-Desmethyl imatinib) is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.Formel:C28H29N7OReinheit:98.60%Farbe und Form:Off-White To Pale-Yellow SolidMolekulargewicht:479.58Ref: TM-T11641
1mg87,00€5mg166,00€10mg303,00€25mg512,00€50mg737,00€100mg1.018,00€1mL*10mM (DMSO)170,00€Dasatinib
CAS:Dasatinib (BMS-354825) is a tyrosine kinase inhibitor that inhibits Src and Bcr-Abl (Ki=16/30 pM) and is orally active and ATP-competitive.Formel:C22H26ClN7O2SReinheit:99.59% - 99.86%Farbe und Form:Pale-Yellow SolidMolekulargewicht:488.01Lyn-IN-1
CAS:Lyn-IN-1 (Bafetinib analog) is a selective and potent dual inhibitor of Bcr-Abl and LynFormel:C30H31F3N8OReinheit:97% - 98.02%Farbe und Form:SolidMolekulargewicht:576.62Ref: TM-T11916
1mg38,00€2mg50,00€5mg79,00€10mg117,00€25mg236,00€50mg371,00€100mg530,00€200mg770,00€1mL*10mM (DMSO)92,00€AKE-72
CAS:AKE-72 is a Pan-BCR-ABL inhibitor with anti-leukemic activity.AKE-72 inhibits the proliferation of Ba/F3 cells expressing natural BCR-ABL or its T315I mutant.Formel:C30H29F3N6OReinheit:98.3%Farbe und Form:SoildMolekulargewicht:546.59Ref: TM-T80676
1mg88,00€2mg129,00€5mg212,00€10mg310,00€25mg479,00€50mg642,00€100mg880,00€200mg1.161,00€SNIPER(ABL)-015
SNIPER(ABL)-015, a compound that conjugates GNF5 (ABL inhibitor) to MV-1 (IAP ligand) via a linker, effectively reduces BCR-ABL protein levels with a DC50 of 5Formel:C58H70F3N9O9Reinheit:98%Farbe und Form:SolidMolekulargewicht:1094.23ML 2-23
ML 2-23 is a potent BCR-ABL degrader operating as a PROTAC, exhibiting selective proteasome-dependent degradation of BCR-ABL within leukemia cells [1].Formel:C47H53BrCl2N10O7SReinheit:98%Farbe und Form:SolidMolekulargewicht:1052.86PROTAC BCR-ABL Degrader-1
PROTAC BCR-ABL Degrader-1 (compound PROTAC 1), featuring a 2-oxoethyl linker, promotes Bcr-Abl degradation through the ubiquitin-proteasome pathway andFormel:C43H40N10O6Reinheit:98%Farbe und Form:SolidMolekulargewicht:792.84FDA-Approved Kinase Inhibitor Library
A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.
Farbe und Form:LiquidDPH
CAS:DPH is a potent cell permeable activator of c-Abl. It shows potent enzymatic and cellular activity in stimulating c-Abl activation.Formel:C18H13FN4O2Reinheit:99.65%Farbe und Form:SolidMolekulargewicht:336.32SNIPER(ABL)-050
SNIPER(ABL)-050 is a chemical compound that combines Imatinib, an ABL inhibitor, with MV-1, an IAP ligand, using a linker.Formel:C68H84N12O9Reinheit:98%Farbe und Form:SolidMolekulargewicht:1213.47SNIPER(ABL)-058
CAS:SNIPER(ABL)-058, a compound that links Imatinib (ABL inhibitor) with a derivative of LCL161 (IAP ligand) through a linker, effectively decreases BCR-ABL proteinFormel:C62H75N11O9SReinheit:98%Farbe und Form:SolidMolekulargewicht:1150.39SNIPER(ABL)-047
SNIPER(ABL)-047, a compound that links HG-7-85-01 (an ABL inhibitor) to MV-1 (an IAP ligand) via a linker, effectively decreases the BCR-ABL protein levels,Formel:C67H82F3N11O9SReinheit:98%Farbe und Form:SolidMolekulargewicht:1274.5Abl Cytosolic Substrate
CAS:Abl Cytosolic Substrate is a substrate for Abelson tyrosine kinase (Abl ).Formel:C64H101N15O16Reinheit:98%Farbe und Form:SolidMolekulargewicht:1336.58FGFRs-IN-1
FGFRs-IN-1 (Compound A16) is an orally active inhibitor targeting FGFR1/2/3/4, with IC50 values of 2.3, 7, 11, and 163 nM respectively. It also inhibits VEGFR1/2/3, Abl, and Flt3, with IC50 values of 61, 176, 112, 26, and 353 nM. The compound shows weak inhibition of CYP enzymes. FGFRs-IN-1 reduces the expression of α-SMA and collagen I, and it inhibits epithelial-mesenchymal transition (EMT) in A549 cells stimulated by TGF-β1. Additionally, FGFRs-IN-1 demonstrates anti-inflammatory activity in mouse models of lung fibrosis induced by Bleomycin and liver fibrosis induced by CCl4.Formel:C28H26Cl2N4O3Farbe und Form:SolidMolekulargewicht:537.44PROTAC BCR-ABL1 ligand 1
CAS:GMB-475 is a PROTAC ligand targeting BCR-ABL1 for degradation via E3 ligase recruitment.Formel:C17H12F3N3O2Farbe und Form:SoildMolekulargewicht:347.29
